GSK (GLAXF) Construction In Progress: $0 Mil (As of Mar. 2026)


GLAXF GSK PLC GLAXF
75 GF Score
Price $25.33
GF Value $21.80
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is GSK Construction In Progress?

GSK GLAXF -5.57% 75 Construction In Progress is $0 Mil as of Mar. 2026. GuruFocus rates GLAXF with a GF Score™ of 75/100 and a GF Value™ of $21.80 (Modestly Overvalued). The stock has 1 warning sign investors should review.

GSK's quarterly construction in progress increased from Sep. 2025 ($0 Mil) to Dec. 2025 ($3,361 Mil) but then declined from Dec. 2025 ($3,361 Mil) to Mar. 2026 ($0 Mil).

GSK's annual construction in progress increased from Dec. 2023 ($2,684 Mil) to Dec. 2024 ($2,933 Mil) and increased from Dec. 2024 ($2,933 Mil) to Dec. 2025 ($3,361 Mil).

GSK Construction In Progress Historical Data

* Premium members only.

The historical data trend for GSK's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK Construction In Progress Chart

GSK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,327.13 2,253.35 2,683.54 2,933.00 3,361.45

GSK Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 3,361.45 0.00
GLAXF
75GF Score
GSK PLC GLAXF
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GSK Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $0 Mil mean?
GSK (GLAXF) has a Construction In Progress of $0 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on GSK and its competitors.
Is GSK's Construction In Progress too high?
GSK's current Construction In Progress is $0 Mil. Overall, GSK has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does GSK's Construction In Progress compare to LLY and JNJ?
GSK's Construction In Progress of $0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on GSK and its competitors. GSK's current Construction In Progress is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GSK stock overvalued right now?
Based on GuruFocus' analysis, GSK (GLAXF) is currently considered Modestly Overvalued. The stock's GF Value™ is $21.80, compared to a current price of $25.33 — trading 16.2% above its estimated fair value. The current Construction In Progress is $0 Mil. GSK's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For GSK (GLAXF), the current Construction In Progress is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GSK (GLAXF) Overvalued in 2026?

Based on GuruFocus' analysis, GSK stock appears to be overvalued. The current stock price of $25.33 is trading 16.2% above its estimated GF Value™ of $21.80. GuruFocus considers GSK to be Modestly Overvalued.

Key valuation signals for GLAXF:

  • Construction In Progress: $0 Mil
  • GF Value™: $21.80 vs. price of $25.33 (16.2% above fair value)
  • GF Score™: 75/100 with 1 warning sign

No single metric tells the full story. See the GLAXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GSK Business Description

Address 79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
75GF Score

Get the complete analysis for GLAXF

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.33
Price
$21.80
GF Value